Utilising exhaled nitric oxide information to enhance diagnosis and therapy of respiratory disease – current evidence for clinical practice and proposals to improve the methodology

References

• Minning DM, Gow AJ, Bonaventura J, et al. Ascaris haemoglobin is a nitric oxide-activated ‘deoxygenase’. Nature. 1999;401:497–502.
   PubMed Web of Science ®Google Scholar
• Gustafsson LE, Leone A, Persson M, et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun. 1991;181:852–857.
   PubMed Web of Science ®Google Scholar
• [cited Sep 22]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=exhaled+nitric+oxide.
   Google Scholar
• ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005; 171:912–930.
   PubMed Web of Science ®Google Scholar
• Högman M, Strömberg S, Schedin U, et al. Nitric oxide from the human respiratory tract efficiently quantified by standardized single breath measurements. Acta Physiol Scand. 1997;159:345–346.
   PubMedGoogle Scholar
• Silkoff PE, McClean PA, Slutsky AS, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med. 1997;155:260–267.
   PubMed Web of Science ®Google Scholar
• Fick A. Die Medizinische Physik. Braunschweig: Druck und Verlag von Friedrich Vieweg und son; 1856.
   Google Scholar
• George SC, Högman M, Permutt S, et al. Modeling pulmonary nitric oxide exchange. J Appl Physiol. 2004;96:831–839.
   PubMed Web of Science ®Google Scholar
• Eckel SP, Linn WS, Berhane K, et al. Estimation of parameters in the two-compartment model for exhaled nitric oxide. Plos One. 2014;9:e85471.
   PubMed Web of Science ®Google Scholar
• Högman M, Thornadtsson A, Hedenstierna G, et al. A practical approach to the theoretical models to calculate NO parameters of the respiratory system. J Breath Res. 2014;8:016002.
   Web of Science ®Google Scholar
• Sepponen A, Lehtimaki L, Huhtala H, et al. Alveolar and bronchial nitric oxide output in healthy children. Pediatr Pulmonol. 2008;43:1242–1248.
   PubMed Web of Science ®Google Scholar
• Högman M, Lafih J, Meriläinen P, et al. Extended NO analysis in a healthy subgroup of a random sample from a Swedish population. Clin Physiol Funct Imaging. 2009;29:18–23.
   PubMed Web of Science ®Google Scholar
• Ricciardolo FL, Sterk PJ, Gaston B, et al. Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004;84:731–765.
   PubMed Web of Science ®Google Scholar
• Högman M, Malinovschi A, Norbäck D, et al. Added value with extended NO analysis in atopy and asthma. Clin Physiol Funct Imaging. 2011;31:294–299.
   PubMed Web of Science ®Google Scholar
• Högman M, Holmkvist T, Wegener T, et al. Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir Med. 2002;96:24–30.
   PubMed Web of Science ®Google Scholar
• Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med. 2001;163:1557–1561.
   PubMed Web of Science ®Google Scholar
• Cameli P, Bargagli E, Refini RM, et al. Exhaled nitric oxide in interstitial lung diseases. Respir Physiol Neurobiol. 2014;197:46–52.
   PubMed Web of Science ®Google Scholar
• Brindicci C, Ito K, Resta O, et al. Exhaled nitric oxide from lung periphery is increased in COPD. EurRespirJ. 2005;26:52–59.
   PubMed Web of Science ®Google Scholar
• Degano B, Mittaine M, Guenard H, et al. Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis. J Appl Physiol. 2009;107:139–143.
   PubMed Web of Science ®Google Scholar
• Hua-Huy T, Nn L-D, Duong-Quy S, et al. Increased alveolar nitric oxide concentration is related to nocturnal oxygen desaturation in obstructive sleep apnoea. Nitric Oxide. 2015;45:27–34.
   PubMed Web of Science ®Google Scholar
• Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. EurRespirJ. 1993;6:1368–1370.
   PubMed Web of Science ®Google Scholar
• Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994;343:133–135.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Emergence of biomolecular pathways to define novel asthma phenotypes type-2 Immunity and beyond. Am J Respir Cell Mol Biol. 2016;55:1–4.
   PubMed Web of Science ®Google Scholar
• Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998;53:91–95.
   PubMed Web of Science ®Google Scholar
• Berlyne GS, Parameswaran K, Kamada D, et al. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol. 2000;106:638–644.
   PubMed Web of Science ®Google Scholar
• Payne DN, Adcock IM, Wilson NM, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001;164:1376–1381.
   PubMed Web of Science ®Google Scholar
• Warke TJ, Fitch PS, Brown V, et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax. 2002;57:383–387.
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47:410–419.
   PubMed Web of Science ®Google Scholar
• Kostikas K, Papaioannou AI, Tanou K, et al. Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season. Chest. 2008;133:906–913.
   PubMed Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, et al., American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels for Clinical A. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–615.
   PubMed Web of Science ®Google Scholar
• Harman SE, Tappenden P, Essat M, et al. Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NO breath. Health Technol Assess. 2015;19:1–330.
   PubMed Web of Science ®Google Scholar
• Sato S, Saito J, Sato Y, et al. Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough. Respir Med. 2008;102:1452–1459.
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Martin RJ, King TS, et al., Asthma Clinical Research Network of the National Heart L, Blood I. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109:410–418.
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol. 2005;115:233–242.
   PubMed Web of Science ®Google Scholar
• Cowan DC, Cowan JO, Palmay R, et al. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax. 2010;65:384–390.
   PubMed Web of Science ®Google Scholar
• Cowan DC, Taylor DR, Peterson LE, et al. Biomarker-based asthma phenotypes of corticosteroid response. J Allergy Clin Immunol. 2015;135(877–83):e1.
   Google Scholar
• Lehtimäki L, Csonka P, Mäkinen E, et al. Predictive value of exhaled nitric oxide in the management of asthma: a systematic review. Eur Respir J. 2016;48:706–714.
   PubMed Web of Science ®Google Scholar
• Gelb AF, Flynn TC, Shinar CM, et al. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest. 2006;129:1492–1499.
   PubMed Web of Science ®Google Scholar
• Ozier A, Girodet PO, Bara I, et al. Control maintenance can be predicted by exhaled NO monitoring in asthmatic patients. Respir Med. 2011;105:989–996.
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Ten Brinke A, Pj S, et al., investigators B. Frequent exacerbators–a distinct phenotype of severe asthma. Clin Exp Allergy. 2014;44:212–221.
   PubMed Web of Science ®Google Scholar
• Little SA, Chalmers GW, MacLeod KJ, et al. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax. 2000;55:232–234.
   PubMed Web of Science ®Google Scholar
• Michils A, Baldassarre S, van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J. 2008;31:539–546.
   PubMed Web of Science ®Google Scholar
• Perez-de-Llano LA, Carballada F, Castro Anon O, et al. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. Eur Respir J. 2010;35:1221–1227.
   PubMed Web of Science ®Google Scholar
• Kupczyk M, Haque S, Middelveld RJ, et al. Phenotypic predictors of response to oral glucocorticosteroids in severe asthma. Respir Med. 2013;107:1521–1530.
   PubMed Web of Science ®Google Scholar
• Essat M, Harnan S, Gomersall T, et al. Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review. Eur Respir J. 2016;47:751–768.
   PubMed Web of Science ®Google Scholar
• Malinovschi A, Fonseca JA, Jacinto T, et al. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol. 2013;132(821–7):e1–5.
   Google Scholar
• Petsky HL, Kew KM, Chang AB. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev. 2016;11:CD011439. .
   PubMedGoogle Scholar
• Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365:1088–1098.
   PubMed Web of Science ®Google Scholar
• Hanania NA, Korenblat P, Chapman KR, et al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2016;4:781–796.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380:651–659.
   PubMed Web of Science ®Google Scholar
• Högman M, Meriläinen P. Guidance for a personal target value of FeNO in allergic asthma: case report and theoretical example. Upsj Med Sci. 2013;118:59–61.
   PubMed Web of Science ®Google Scholar
• Silkoff PE, Sylvester JT, Zamel N, et al. Airway nitric oxide diffusion in asthma. role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med. 2000;161:1218–1228.
   PubMed Web of Science ®Google Scholar
• Pedroletti C, Högman M, Meriläinen P, et al. Nitric oxide airway diffusing capacity and mucosal concentration in asthmatic schoolchildren. Pediatr Res. 2003;54:496–501. Epub 2003/07/04.
   PubMed Web of Science ®Google Scholar
• Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J. 2001;18:635–639.
   PubMed Web of Science ®Google Scholar
• Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur Respir J. 2002;20:841–845.
   PubMed Web of Science ®Google Scholar
• Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Peripheral inflammation in patients with asthmatic symptoms but normal lung function. J Asthma. 2005;42:605–609.
   PubMed Web of Science ®Google Scholar
• Berry M, Hargadon B, Morgan A, et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory astma. Eur Respir J. 2005;25:989–991.
   Web of Science ®Google Scholar
• Malinovschi A, Ludviksdottir D, Tufvesson E, et al. Application of nitric oxide measurements in clinical conditions beyond asthma. Eur Clin Respir J. 2015;2:28517.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Weitzberg E, Nordvall SL, et al. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener’s syndrome. Eur Respir J. 1994;7:1501–1504. Epub 1994/08/01.
   PubMed Web of Science ®Google Scholar
• Lucas JS, Barbato A, Collins SA, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. 2016.
   Web of Science ®Google Scholar
• Phillips PS, Sacks R, Marcells GN, et al. Nasal nitric oxide and sinonasal disease: a systematic review of published evidence. Otolaryngol Head Neck Surg. 2011;144:159–169.
   PubMed Web of Science ®Google Scholar
• Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD. Eur Respir J. 2010;35:72–78.
   PubMed Web of Science ®Google Scholar
• Clini E, Cremona G, Campana M, et al. Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment. Am J Respir Crit Care Med. 2000;162:446–450.
   PubMed Web of Science ®Google Scholar
• Malerba M, Radaeli A, Olivini A, et al. Exhaled nitric oxide as a biomarker in COPD and related comorbidities. Biomed Res Int. 2014;2014:271918.
   PubMed Web of Science ®Google Scholar
• Lim CS, Rani FA, Tan LE. Response of exhaled nitric oxide to inhaled corticosteroids in patients with stable COPD: a systematic review and meta-analysis. Clin Respir J. 2016.
   Google Scholar
• Kunisaki KM, Rice KL, Janoff EN, et al. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study. Ther Adv Respir Dis. 2008;2:55–64.
   PubMedGoogle Scholar
• Soter S, Barta I, Antus B. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide. Inflammation. 2013;36:1178–1185.
   PubMed Web of Science ®Google Scholar
• Malinovschi A, Janson C, Holmkvist T, et al. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. EurRespirJ. 2006;28:339–345.
   PubMed Web of Science ®Google Scholar
• Gunnarsson L, Tokics L, Lundquist H, et al. Chronic obstructive pulmonary disease and anesthesia: formation of atelectasis and gas exchange impairment. Eur Respir J. 1991;4:1106–1116.
   PubMed Web of Science ®Google Scholar
• Gelb AF, Flynn TC, Krishnan A, et al. Central and peripheral airway sites of nitric oxide gas exchange in COPD. Chest. 2010;137:575–584.
   PubMed Web of Science ®Google Scholar
• Williamson PA, Clearie K, Menzies D, et al. Assessment of small-airways disease using alveolar nitric oxide and impulse oscillometry in asthma and COPD. Lung. 2011;189:121–129.
   PubMed Web of Science ®Google Scholar
• Malinovschi A, Janson C, Holmkvist T, et al. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J. 2006;28:339–345.
   PubMed Web of Science ®Google Scholar
• Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD. Eur Respir J. 2010;35:72–78.
   PubMed Web of Science ®Google Scholar
• McCurdy MR, Sharafkhaneh A, Abdel-Monem H, et al. Exhaled nitric oxide parameters and functional capacity in chronic obstructive pulmonary disease. J Breathres. 2011;5:016003.
   Web of Science ®Google Scholar
• Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. the report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22:667–689.
   PubMed Web of Science ®Google Scholar
• Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001;163:685–689.
   PubMed Web of Science ®Google Scholar
• Rivas E, Arismendi E, Agusti A, et al. Ventilation/perfusion distribution abnormalities in morbidly obese subjects before and after bariatric surgery. Chest. 2015;147:1127–1134.
   PubMed Web of Science ®Google Scholar
• Arismendi E, Rivas E, Agusti A, et al. The systemic inflammome of severe obesity before and after bariatric surgery. Plos One. 2014;9:e107859.
   PubMed Web of Science ®Google Scholar
• Bikov A, Hull JH, Kunos L. Exhaled breath analysis, a simple tool to study the pathophysiology of obstructive sleep apnoea. Sleep Med Rev. 2016;27:1–8.
   PubMed Web of Science ®Google Scholar
• Chua AP, Aboussouan LS, Minai OA, et al. Long-term continuous positive airway pressure therapy normalizes high exhaled nitric oxide levels in obstructive sleep apnea. J Clin Sleep Med. 2013;9:529–535.
   PubMed Web of Science ®Google Scholar
• Tichanon P, Wilaiwan K, Sopida S, et al. Effect of continuous positive airway pressure on airway inflammation and oxidative stress in patients with obstructive sleep apnea. Can Respir J. 2016;2016:3107324.
   PubMed Web of Science ®Google Scholar
• Kotecha J, Shulgina L, Sexton DW, et al. Plasma vascular endothelial growth factor concentration and alveolar nitric oxide as potential predictors of disease progression and mortality in idiopathic pulmonary fibrosis. J Clin Med. 2016;5.
   Web of Science ®Google Scholar
• Kp T, Nn L-D, Duong-Quy S, et al. Exhaled nitric oxide, but not serum nitrite and nitrate, is a marker of interstitial lung disease in systemic sclerosis. Nitric Oxide. 2009;20:200–206.
   PubMed Web of Science ®Google Scholar
• Tiev KP, Cabane J, Aubourg F, et al. Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide. Eurrespir J. 2007;30:26–30.
   PubMed Web of Science ®Google Scholar
• Wuttge DM, Bozovic G, Hesselstrand R, et al. Increased alveolar nitric oxide in early systemic sclerosis. Clin Exprheumatol. 2010;28:S5–S9.
   Web of Science ®Google Scholar
• Kp T, Hua-Huy T, Kettaneh A, et al. Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma. Thorax. 2012;67:157–163.
   PubMed Web of Science ®Google Scholar
• Tiev KP, Coste J, Ziani M, et al. Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26:32–38.
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Shibuya K, Nakamura M, et al. Dose–volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys. 2012;83:e545–9.
   PubMed Web of Science ®Google Scholar
• Guerrero T, Martinez J, McCurdy MR, et al. Elevation in exhaled nitric oxide predicts for radiation pneumonitis. Int J Radiat oncol biol Phys. 2011.
   PubMed Web of Science ®Google Scholar
• Moré JM, Eclov NC, Chung MP, et al. Feasibility and potential utility of multicomponent exhaled breath analysis for predicting development of radiation pneumonitis after stereotactic ablative radiotherapy. J Thorac Oncol. 2014;9:957–964.
   PubMed Web of Science ®Google Scholar
• Enache I, Noel G, Jeung MY, et al. Can exhaled NO fraction predict radiotherapy-induced lung toxicity in lung cancer patients? Radiat Oncol. 2012;7:117.
   PubMed Web of Science ®Google Scholar
• Kamp DW, Graceffa P, Pryor WA, et al. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med. 1992;12:293–315.
   PubMed Web of Science ®Google Scholar
• Kamp DW, Weitzman SA. The molecular basis of asbestos induced lung injury. Thorax. 1999;54:638–652.
   PubMed Web of Science ®Google Scholar
• Sandrini A, Johnson AR, Thomas PS, et al. Fractional exhaled nitric oxide concentration is increased in asbestosis and pleural plaques. Respirology. 2006;11:325–329.
   PubMed Web of Science ®Google Scholar
• Lehtimäki L, Oksa P, Järvenpää R, et al. Pulmonary inflammation in asbestos-exposed subjects with borderline parenchymal changes on HRCT. Respir Med. 2010;104:1042–1049.
   PubMed Web of Science ®Google Scholar
• Lehtonen H, Oksa P, Lehtimäki L, et al. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax. 2007;62:602–607.
   PubMed Web of Science ®Google Scholar
• Shukla A, Gulumian M, Hei TK, et al. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med. 2003;34:1117–1129.
   PubMed Web of Science ®Google Scholar
• Sauni R, Oksa P, Lehtimäki L, et al. Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers. Occup Environ Med. 2012;69:256–260.
   PubMed Web of Science ®Google Scholar
• Lee JS, Shin JH, Lee JO, et al. Levels of exhaled breath condensate ph and fractional exhaled nitric oxide in retired coal miners. Toxicol Res. 2010;26:329–337.
   PubMedGoogle Scholar
• Brichet A, Tonnel AB, Brambilla E, et al., Groupe d’Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du N. Chronic interstitial pneumonia with honeycombing in coal workers. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:211–219.
   PubMed Web of Science ®Google Scholar